Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial (Q35540009)
Jump to navigation
Jump to search
scientific article published on 22 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial |
scientific article published on 22 August 2011 |
Statements
1 reference
Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial (English)
1 reference
Peter C Taylor
1 reference
Emilia Quattrocchi
1 reference
Stephen Mallett
1 reference
Regina Kurrasch
1 reference
Jørgen Petersen
1 reference
David J Chang
1 reference
22 August 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference